Sato K, Hirano I, Sekine H, Miyauchi K, Nakai T, Kato K, Ito S, Yamamoto M, Suzuki N*.

An immortalized cell line derived from renal erythropoietin-producing (REP) cells demonstrates their potential to transform into myofibroblasts.

Sci Rep. 2019 Aug 2;9(1):11254. doi: 10.1038/s41598-019-47766-5.

Hirano I and Suzuki N* (2019) The Neural Crest as the First Production Site of the Erythroid Growth Factor Erythropoietin.

Front Cell Dev Biol 7:105. doi: 10.3389/fcell.2019.00105

Sato K, Kumagai N, Suzuki N* (2019) Alteration of the DNA methylation signature of renal erythropoietin-producing cells governs the sensitivity to drugs targeting the hypoxia-response pathway in kidney disease progression. Front Genet 10:1134.doi: 10.3389/fgene.2019.01134.

Sato, K, Hirano, I, Sekine, H, Miyauchi, K, Nakai, T, Kato, K, Ito, S, Yamamoto, M, Suzuki, N.

"A cell line derived from renal erythropoietin-producing cells provese their myofibroblast-transformation property"

International Society of Nephrology World Congress, Melbourne, Australia, April 12-15, 2019（Poster）Abstract in Kidney Int Rep 4, S54 (2019)

Norio Suzuki

“Hypoxia-inducible Epo gene regulation in renal erythropoietin producing (REP) cells and its association with iron metabolism, erythropoiesis, and disease”

Seminar in National Taiwan University, Taipei, Taiwan, Nov 4, 2019